Audit of B-INTERFERON treatment: Experience in the first 100 patients within the walton centre MS service

被引：0
|
作者：
Rog, DJ [1 ]
Young, CA [1 ]
Boggild, MD [1 ]
机构：
[1] Walton Ctr Neurol & Neurosurg, Liverpool, Merseyside, England
来源：
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | 2002年 / 73卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：228 / 228
页数：1
相关论文
共 50 条
  • [21] Treatment outcome in patients of hepatitis B with hepatitis D: Experience of 4 years at a tertiary care centre in Pakistan
    Zuberi, Bader Faiyaz
    Quraishy, Muhammad Saeed
    Afsar, Salahuddin
    Akhtar, Naheed
    Kumar, Ashok
    Dodani, Sunil Kumar
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2007, 17 (06): : 320 - 322
  • [22] Efficacy and tolerability of recombinant interferon-alpha2b/ribavirin combination therapy for patients with chronic hepatitis C: Out-of-trial audit of first treatment and retreatment.
    Kumar, D
    Wallington-Beddoe, C
    George, J
    Lin, R
    Samarasinghe, D
    Liddle, C
    Farrell, G
    HEPATOLOGY, 2002, 36 (04) : 600A - 600A
  • [23] Treatment persistence and clinical outcomes in patients starting B cell depleting therapies within the Swiss MS Cohort
    Disanto, Giulio
    Schaedelin, Sabine
    Oechtering, Johanna
    Lorscheider, Johannes
    Galbusera, Riccardo
    Finkener, Sebastian
    Achtnichts, Lutz
    Lalive, Patrice
    Mueller, Stefanie
    Pot, Caroline
    Hoepner, Robert
    Salmen, Anke
    Zecca, Chiara
    Hemkens, Lars G.
    D'Souza, Marcus
    Fischer-Barnicol, Bettina
    Du Pasquier, Renaud
    Roth, Patrick
    Yaldizli, Ozgur
    Einsiedler, Maximilian
    Derfuss, Tobias
    Kappos, Ludwig
    Gobbi, Claudio
    Granziera, Cristina
    Uginet, Marjolaine
    Maceski, Aleksandra Maleska
    Mcdonald, Keltie
    Leppert, David
    Benkert, Pascal
    Kuhle, Jens
    Swiss MS Cohort Study
    MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2025, 11 (01)
  • [24] Alemtuzumab as first- and second-line treatment in patients with Sézary syndrome-The experience of a tertiary centre
    Nogueira, Miguel
    Lau, Catarina
    Teixeira, Maria dos Anjos
    Peixeiro, Rita
    Cabral, Renata
    Fernandes, Iolanda
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2024, 38 (01) : E86 - E88
  • [25] Risks of pulmonary vein isolation by radiofrequency for the treatment of paroxysmal atrial fibrillation: a single centre experience of the first 200 patients
    Albenque, J. P.
    Boveda, S.
    Henguelle, O.
    Combes, N.
    Belhocine, M.
    Dongay, B.
    Hocini, M.
    Besse, J.
    Quedreux, J. F.
    Donzeau, J. P.
    ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 2006, 99 (09): : 771 - 774
  • [26] Neutralizing antibodies during treatment of multiple sclerosis with interferon beta-1b: Experience during the first three years
    Duquette, P
    Girard, M
    Dubois, R
    Kobler, RL
    Lublin, F
    Kelley, L
    Francis, GS
    Freedman, M
    Greenstein, JI
    Mishra, B
    DeLillio, N
    Whitaker, J
    Layton, B
    Sibley, WA
    Laguna, J
    Krikawa, J
    Paty, DW
    Oger, JJ
    Kastrukoff, LF
    Morrison, W
    Nelson, J
    Goodin, D
    Massa, SM
    Gutteridge, E
    Arnason, BGW
    Noronha, A
    Reder, AT
    Martia, R
    Ebers, GC
    Rice, GPA
    Lesaux, J
    Johnson, KP
    Panitch, HS
    Bever, CT
    Conway, K
    Li, DKB
    Tanton, EL
    Zhao, GJ
    Flak, B
    Riddebough, A
    Cover, K
    Rhodes, B
    Cook, A
    Smith, K
    Costley, L
    Renneberg, S
    Shaw, T
    Genton, M
    vandenNoort, S
    Weinshenker, B
    NEUROLOGY, 1996, 47 (04) : 889 - 894
  • [27] Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in the Treatment of HIV-Infected Patients: Experience with the First 100 Patients from Qatar
    Al Soub, Hussam
    Al-khal, A. Latif M.
    Alsoub, Deema
    Awouda, Waleed
    CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2020, 2020
  • [28] Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes
    Kappos, L.
    Polman, C. H.
    Freedman, M. S.
    Edan, G.
    Hartung, H. P.
    Miller, D. H.
    Montalban, X.
    Barkhof, F.
    Bauer, L.
    Jakobs, P.
    Pohl, C.
    Sandbrink, R.
    NEUROLOGY, 2006, 67 (07) : 1242 - 1249
  • [29] Treatment of mild chronic hepatitis C with interferon α-2b:: results of a multi-centre randomized study in 80 patients
    Queneau, PE
    Osaer, F
    Bronowicki, JP
    Monnot, B
    Thiefin, G
    Bettinger, D
    Carbillet, JP
    Raabe, JJ
    Fratte, S
    Minello-Franza, A
    Bresson-Hadni, S
    Miguet, JP
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2001, 13 (02) : 143 - 147
  • [30] Audit of Treatment Duration of Dual Anti-platelet Therapy in Patients Post ACS and Elective PCI. A Single Centre Experience in Beaumont Hospital
    Cuddy, S.
    Collis, R.
    Matiullah, S.
    Salim, T.
    Elhanan, M.
    Hamra, M.
    Sheahan, R.
    Foley, D.
    McAdam, B.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2014, 183 : S406 - S407
12345